Application Nr Approved Date Route Status External Links
ANDA207271 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mesalamine Extended-Release Capsules Are Indicated For The Maintenance Of Remission Of Ulcerative Colitis In Patients 18 Years Of Age And Older. • Mesalamine Extended-Release Capsules Are A Locally-Acting Aminosalicylate Indicated For The Maintenance Of Remission Of Ulcerative Colitis In Adults. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments